SCAR Updates
Dr. Benjamin Kaffenberger discusses three high-yield updates in managing and treating severe cutaneous adverse reactions, including differentiating high-risk drug eruptions from low-risk drug eruptions, the use of validated instruments for their diagnosis and drug attribution, and SJS controversies. Benjamin Kaffenberger, MD, MS, is Clinical Associate Professor of Dermatology, The Ohio State University, Columbus, Ohio “Drug […]